Discovery of novel nonsteroidal VDR agonists with novel diarylmethane skeleton for the treatment of breast cancer (vol 163, pg 787, 2019)

被引：0
|
作者：
Wang, Cong [1 ]
Wang, Bin [1 ]
Hou, Siyuan [1 ]
Xue, Lingjing [1 ]
Kang, Zisheng [1 ]
Du, Junjie [1 ]
Li, Yanyi [1 ]
Liu, Xuwentai [1 ]
Wang, Qianqian [1 ]
Zhang, Can [1 ]
机构：
[1] China Pharmaceut Univ, State Key Lab Nat Med, Jiangsu Key Lab Drug Discovery Metab Dis, Ctr New Drug Discovery, 24 Tong Jia Xiang, Nanjing 210009, Peoples R China
来源：
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | 2020年 / 186卷
关键词：
D O I：
10.1016/j.ejmech.2019.111907
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Milk derived colloid as a novel drug delivery carrier for breast cancer (vol 16, pg 1184, 2015)
    Hayashi, Masamichi
    Silanikove, Nissim
    Chang, Xiaofei
    Ravi, Rajani
    Pham, Vui
    Baia, Gilson
    Paz, Keren
    Brait, Mariana
    Koch, Wayne M.
    Sidransky, David
    CANCER BIOLOGY & THERAPY, 2015, 16 (10) : 1567 - 1567
  • [32] Discovery of novel G9a/GLP covalent inhibitors for the treatment of triple-negative breast cancer
    Zhang, Qiangsheng
    Chang, Bo
    Feng, Qiang
    Li, Lu
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 261
  • [33] Discovery of Novel Polycyclic Heterocyclic Derivatives from Evodiamine for the Potential Treatment of Triple-Negative Breast Cancer
    Xu, Shengtao
    Yao, Hong
    Qiu, Yangyi
    Zhou, Manzhen
    Li, Dahong
    Wu, Liang
    Yang, Dong-Hua
    Chen, Zhe-Sheng
    Xu, Jinyi
    JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (23) : 17346 - 17365
  • [34] Discovery and optimization of withangulatin A derivatives as novel glutaminase 1 inhibitors for the treatment of triple-negative breast cancer
    Zhou, Wu-Xi
    Chen, Chen
    Liu, Xiao-Qin
    Li, Ying
    Lin, Yao-Lan
    Wu, Xiu-Tao
    Kong, Ling-Yi
    Luo, Jian-Guang
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 210
  • [35] Shared genetics between breast cancer and predisposing diseases identifies novel breast cancer treatment candidates (vol 18, 124, 2024)
    Lalagkas, Panagiotis N.
    Melamed, Rachel D.
    HUMAN GENOMICS, 2025, 19 (01)
  • [36] Horizon scanning for novel therapeutics for the treatment of prostate cancer (Retraction of vol 19, pg 1487, 2010)
    Bianchini, Diletta
    Zivi, Andrea
    Sandhu, Shahneen
    de Bono, Johann S.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2012, 21 (10) : 1591 - 1591
  • [37] Hits and misses in novel pancreatic and rectal cancer treatment options (vol 115, pg 545, 2023)
    Chuong, M. D.
    Anker, C. J.
    Buckstein, M. H.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (05): : 1302 - 1302
  • [38] Novel Therapeutic Strategies for Castration Resistant Prostate Cancer: Inhibition of Persistent Androgen Production and Androgen Receptor Mediated Signaling (vol 185, pg 787, 2011)
    Molina, A.
    JOURNAL OF UROLOGY, 2011, 186 (02): : 762 - 762
  • [39] The discovery of a novel series of potential ERRα inverse agonists based on p-nitrobenzenesulfonamide template for triple-negative breast cancer in vivo
    Gao, Zhipei
    Wang, Tianxiao
    Li, Rui
    Du, Yongli
    Lv, Han
    Zhang, Liudi
    Chen, Haifei
    Shi, Xiaojin
    Li, Qunyi
    Shen, Jingkang
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2022, 37 (01) : 125 - 134
  • [40] Discovery and description of a novel sexual weapon in the world's most widely-studied freshwater turtle (vol 33, pg 889, 2019)
    Hawkshaw, Deborah M.
    Moldowan, Patrick D.
    Litzgus, Jacqueline D.
    Brooks, Ronald J.
    Rollinson, Njal
    EVOLUTIONARY ECOLOGY, 2020, 34 (01) : 147 - 148
12345